Mass spectrometry with stable isotope labels has been seminal in discovering the dynamic state of living matter 1,2 , but is limited to bulk tissues or cells. We developed multi-isotope imaging mass spectrometry (MIMS) that allowed us to view and measure stable isotope incorporation with submicrometre resolution 3,4 . Here we apply MIMS to diverse organisms, including Drosophila, mice and humans. We test the 'immortal strand hypothesis', which predicts that during asymmetric stem cell division chromosomes containing older template DNA are segregated to the daughter destined to remain a stem cell, thus insuring lifetime genetic stability. After labelling mice with 15 N-thymidine from gestation until post-natal week 8, we find no 15 N label retention by dividing small intestinal crypt cells after a four-week chase. In adult mice administered 15 Nthymidine pulse-chase, we find that proliferating crypt cells dilute the 15 N label, consistent with random strand segregation. We demonstrate the broad utility of MIMS with proof-of-principle studies of lipid turnover in Drosophila and translation to the human haematopoietic system. These studies show that MIMS provides high-resolution quantification of stable isotope labels that cannot be obtained using other techniques and that is broadly applicable to biological and medical research.
The cell surface was sputtered to reach the nuclei. Left, differential interference contrast reflection microscopy. Middle, 14 N image revealing subcellular details including the nucleus (white arrows) with nucleoli. Right, hue saturation intensity (HSI) image mapping the 15 N: 14 N ratio. The rainbow scale ranges from blue, set to natural ratio (0.37%, expressed as 0% above natural ratio), to red, where the ratio is several fold above natural ratio (700%, eight times the natural ratio). 15 N labelling is concentrated in the nucleus. Scale bars, 10 mm. b, Fibroblast nuclei after serial or parallel DNA labelling with 15 Nthymidine, 13 Scale bars, 5 mm. e, One group labelled similarly to control cells (undivided), the other with labelling that was approximately half that of control (divided). f, 15 N: 14 N HSI image of the small intestine. 15 N-thymidine labelling (one week) of nuclei extends from the crypts to the tips of the villi. Mosaic: 8 tiles, 80 mm each. Scale bar, 30 mm. g, Sigmoidal dose response curve: 15 N-thymidine labelling after single subcutaneous injection (R 2 5 0.99). also tracked fibroblast division after a 24-h label-free chase (Fig. 1d , e and Supplementary Fig. 3 ). Cells segregated into two populations, one indistinguishable from control cells suggesting no division, the other with halving of label, consistent with one division during the chase.
We found similar results by tracking cell division in vivo in the small intestine ( Fig. 1f , g and Supplementary Figs 4-6). We measured dosedependent 15 N-thymidine incorporation within nuclei of actively dividing crypt cells ( Fig. 1g and Supplementary Fig. 4 ), down to a dose of 0.1 mg per g ( Supplementary Fig. 2 ). The cytoplasm was slightly above natural ratio, probably due to low-level soluble 15 N-thymidine or mitochondrial incorporation ( Supplementary Fig. 2 ). We measured halving of label with each division during label-free chase (Supplementary Fig. 6 ).
We then tested the 'immortal strand hypothesis', a concept that emerged from autoradiographic studies 5 and that predicted long-term label retaining cells in the small intestinal crypt 6, 7 . It proposes that asymmetrically dividing stem cells also asymmetrically segregate DNA, such that older template strands are retained by daughter cells that will remain stem cells and newer strands are passed to daughters committed to differentiation ( Supplementary Fig. 7 ) 5, 6 . Modern studies continue to argue both for [8] [9] [10] [11] [12] or against [13] [14] [15] [16] the hypothesis, leading to the suggestion that definitive resolution of the debate will require a new experimental approach 17 .
Although prior evidence suggests a concentration of label-retaining cells in the 14 anatomic position 7,8 , we searched for DNA label retention irrespective of anatomic position or molecular identity. We labelled mice with 15 N-thymidine for the first 8 weeks of life when intestinal stem cells are proposed to form 8 . After a 4-week chase, mice received bromodeoxyuridine (BrdU) for 24 h before euthanasia to identify proliferating cells ( Fig. 2a and Supplementary Fig. 8 , Experiment 1), specifically crypt base columnar (CBC) cells and transit amplifying cells ( Supplementary Fig. 9 ), which cycle at a rate of one and two times per 24 h, respectively 18 ( Supplementary Fig. 10 ). All crypt cell nuclei were highly labelled upon completion of 15 N-thymidine; after a 4-week chase, however, we found no label retention by non-Paneth crypt cells ( Fig. 2b-f ; n 5 3 mice, 136 crypts analysed). 15 N-labelling in 15 N 1 /BrdU 2 Paneth and mesenchymal cells was equivalent to that measured at pulse completion ( Fig. 2b, c) indicating quiescence during the chase (values above 15 N: 14 N natural ratio: Paneth pulse 5 107.8 6 5.0% s.e.m. n 5 51 versus Paneth pulse-chase 5 96.3 6 2.8% s.e.m. n 5 218; mesenchymal pulse 5 92.0 6 5.0% s.e.m. n 5 89 versus mesenchymal pulse-chase 5 90.5 6 2.2% s.e.m. n 5 543). The number of randomly selected crypt sections was sufficient to detect a frequency as low as one label-retaining stem cell per crypt irrespective of anatomic location within the crypt. Because each anatomic level contains approximately 16 circumferentially arrayed cells 8 , a two-dimensional analysis captures approximately one eighth of the cells at each anatomic position (one on each side of the crypt; Supplementary Fig. 9a ). Therefore, assuming only one label-retaining stem cell per crypt we should have found 17 label-retaining cells in the 136 sampled crypts (one eighth of 136) but we found 0 (binomial test P , 0.0001). The significance of this result held after lowering the expected frequency of label-retaining cells by 25% to account for the development of new crypts, a process thought to continue into adulthood 19 . In three additional experiments, using shorter labelling periods and including in utero development, we also found no label-retaining cells in the crypt other than Paneth cells ( Supplementary Fig. 8 , Experiments 2-4).
To address the possibility that long-term thymidine exposure or frequent high-dose injections introduced pitfalls, we limited labelling to the previously reported peak time period of label-retaining stem cell formation 8 and reduced the dose by 50-fold compared to prior experiments ( Supplementary Fig. 8 , Experiment 5). Approximately six labelretaining cells per intestinal circumference were observed previously 8 with a similar protocol; with about 90 crypts per circumference, this translates to 1 label-retaining cell per 15 sectioned crypts. We analysed 330 crypts and observed 19 15 N 1 /BrdU 2 Paneth cells (one per 17 crypt sections), but no non-Paneth label-retaining cells (expected, 21; observed, 0; binomial test P , 0.0001) or doubly labelled ( 15 N 1 / BrdU 1 ) cells irrespective of cellular identity. Thus, after labelling during all potential periods of stem cell formation, spanning in utero through post-natal development, we found no label-retaining stem cells in the small intestinal crypt other than Paneth cells, which are largely quiescent. We conclude therefore that the phenomenon of label-retaining cells as described by others was most likely due either to reagent toxicity or to insufficient resolution with the consequent misidentification of labelled post-mitotic Paneth cell nuclei as label retaining 14 stem cells. MIMS minimizes these potential artefacts due to its ability to detect non-radioactive isotopes and the high imaging resolution both laterally and vertically. Although our data cannot directly exclude the migration of label-retaining stem cells into the crypt under non-homeostatic conditions such as radiation injury 11 , prior examinations of crypt clones argue against contributions from either a resting stem cell population or from stem cells originating outside the crypt 20 .
We also studied label release in adult mice after stem cell formation. These experiments are particularly relevant given the recent suggestion 
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that crypt stem cells exhibit monoclonal drift over 8 months 21, 22 , a model that is incompatible with lifetime survival of label-retaining stem cells but that does not exclude the possibility of biased template strand segregation. After administering 15 N-thymidine for 2 weeks to label all proliferating crypt cells, 15 N-thymidine was stopped and BrdU was administered for 24 h to label cells dividing during the 15 Nthymidine-free chase (Fig. 3a) . A consequence of the immortal strand hypothesis would be that a stem cell would produce a daughter in which 15 N label was completely lost with the first division during chase ( Supplementary Fig. 7) . We observed no such BrdU 1 / 15 N 2 crypt cells, even after extending the 15 N-thymidine-free chase to 48 h ( Fig. 3b and Supplementary Fig. 11 ). Proliferating (BrdU 1 ) crypt cells (n 5 3mice; 563 cells analysed) diluted 15 N-thymidine label (mean 71% above natural ratio) compared to undivided (BrdU 2 ) cells (129% above natural ratio) or cells analysed at the end of 15 N-thymidine pulse (128% above natural ratio), as expected of cells undergoing random chromosomal segregation (Fig. 3c ). We also analysed crypt cell nuclei in late mitosis, finding 15 N label and BrdU in both sets of segregating chromosomes ( Fig. 3d and Supplementary Fig. 12, n 5 232) . Together, these data result from an analysis of 625 crypts, in which we did not find a single BrdU 1 nucleus or chromosomal complement that was not 15 N-labelled, indicating that dividing cells in the crypt uniformly dilute labelled DNA in a pattern consistent with random DNA strand segregation.
The broad applicability of MIMS is demonstrated by proof-ofprinciple studies in Drosophila and humans. Drosophila provides a model system in which to study the genetics of lipid metabolism, in vivo. Due to its small size, however, it is difficult to obtain sufficient material from specific tissue/cell types for measurement with conventional mass spectrometry. A previous study showed numerous lipid droplets in the enterocytes of a segment of the Drosophila larval intestine, the anterior midgut 23 . We therefore used MIMS to measure the incorporation and turnover of diet-derived 13 C-palmitate within these cells. After larval exposure to dietary 13 C-palmitate, label is incorporated into enterocyte lipid droplets with a subcellular pattern similar to that seen with a neutral lipid dye (compare Fig. 4a with supplementary Fig. 13 ). Dietary 13 C-palmitate pulses of varying periods indicate that the rate of 13 Supplementary Fig. 8 ). b, Dividing cells (BrdU 1 ) dilute 15 N-thymidine label (small arrows) relative to undivided cells (BrdU 2 ) (large arrows). Note two CBC cells with elongated nuclei at the crypt base. Scale bar, 10 mm. c, Divided crypt cells (BrdU 1 ), residing in CBC or 14-10 positions, demonstrated 15 Ndilution consistent with one or two rounds of division during the chase (n 5 3 mice per group). d, Mitotic crypt cell. Segregating chromosomes are visible in 14 N and 31 P images. 15 N-label and BrdU were measured in both segregating chromosomal complements consistent with symmetric chromosomal segregation. Scale bar, 2 mm. RESEARCH LETTER midgut enterocytes than in the adipocytes of the fat body, the major lipid storage depot in Drosophila (Fig. 4a, b ). Pulse-chase experiments with dietary 13 C-palmitate also demonstrate a reproducible exponential decay (R 2 5 0.9) of the 13 C signal within enterocyte lipid droplets and provide an estimate for the half-life of approximately 9 h (Fig. 4c,  d) . These results demonstrate the utility of MIMS for precise measurement of in vivo lipid turnover at high resolution within individual Drosophila lipid droplets.
In the first MIMS human experiment, we administered 15 Nthymidine to a healthy volunteer by intravenous infusion for 48 h. We performed MIMS analysis on peripheral white blood cell smears. We found no labelled white blood cells at the end of the infusion (3,600 analysed). After a 4-week chase we found a few labelled white blood cells (Fig. 4c, 4 of approximately 2,000 cells analysed) consistent with a lag time before release from the bone marrow (chi-squared, P , 0.01). Radiolabelled thymidine has been administered to humans in numerous studies previously 24 , but these studies were conducted primarily on cancer patients. There is no known risk to using stable isotopes 25 . Thus, this experiment now opens the door to studies of metabolism and cell tracking in humans.
In conclusion, we provide direct evidence under physiological conditions against non-random template strand segregation in the small intestine. Our approach encompasses all potential stem cell populations in the crypt, those identifiable by known markers [26] [27] [28] and putative ones not identified by a specific marker. We have demonstrated the power of MIMS to image and quantify cell metabolism in three different contexts: mammalian intestinal cell division, Drosophila lipid metabolism and human lymphopoiesis. We anticipate that the measuring and imaging power of MIMS will make it a major tool to study metabolism and cell fate in animals and humans.
METHODS SUMMARY
Data were acquired with the prototype (four detectors) and a second-generation instrument (NanoSIMS 50L, Cameca: seven detectors). Quantitative mass images were analysed with Open MIMS software, a plug-in to ImageJ (http://www.nrims. harvard.edu/software.php). Stable isotopes were obtained from Cambridge Isotopes ( 15 N-thymidine, 13 C-thymidine) and Sigma-Aldrich ( 13 C-palmitate).
